|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 327.10 CHF | +0.77% |
|
-0.67% | -0.34% |
| 12:32am | Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial | RE |
| 06-05 | Zealand touts promising tolerability data for obesity drug in mid-stage study | RE |
Group Roche Holding AG: Relations chart
Private companies belonging to the same group as ROCHE HOLDING AG
| Company | Manager |
|---|---|
Sapac Corp. Ltd. | - |
Roche Pharmholding BV
 Roche Pharmholding BV Medical DistributorsDistribution Services Manufactures and distributes pharmaceutical and vitamin products | - |
Roche Intertrade Ltd. | - |
Roche Financial Investments Ltd. | - |
Roche Catalyst Investments Ltd. | - |
Roche Financial Management Ltd. | - |
Roche Finance Europe BV
 Roche Finance Europe BV Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | - |
Roche Diagnostics Belgium NV
 Roche Diagnostics Belgium NV BiotechnologyHealth Technology Develops technologies for diagnosis, monitoring, screening and treatment of diseases | - |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition